{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:12:06Z","timestamp":1761027126852,"version":"build-2065373602"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Surgical management of patients with peritoneal surface malignancies (PSM) via multivisceral resection is associated with increased morbidity and mortality in the immediate postoperative period, rendering intensive care therapy critically important. We aimed to determine whether intensive care unit (ICU) course and scoring systems predict not only short-term but also long-term outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively analyzed the medical records of all patients who underwent cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancies (PSM) between 2008 and 2015 at a university cancer center. Upon postoperative ICU admission, Simplified Acute Physiology Score (SAPS II) and Sequential Organ Failure Assessment (SOFA) scores were recorded. Complications during the ICU stay and overall hospitalization were documented, and patients were followed according to a standardized protocol after discharge.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 251 patients were included. The mean Peritoneal Cancer Index (PCI) was 14\u2009\u00b1\u20099.1 and correlated significantly with both ICU stay duration (<jats:italic>p<\/jats:italic>\u2009=\u20090.002) and total hospital stay (<jats:italic>p<\/jats:italic>\u2009=\u20090.001). In-hospital mortality was 2%, and the reoperation rate was 16.7%. SOFA scores on the day of surgery, postoperative days 1, 2, and 7 demonstrated strong correlations with ICU length of stay (all <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.001) and with overall hospital stay (<jats:italic>p<\/jats:italic>\u2009=\u20090.001 for the day of surgery and day 7; <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.001 for days 1 and 2). In multivariate analysis, SOFA score on postoperative day 7 [hazard ratio (HR) 1.261; 95% confidence interval (CI) 1.120\u20131.421; <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.001] and SAPS II on the day of surgery (HR 1.042; 95% CI 1.017\u20131.068; <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.001) emerged as independent predictors of overall survival.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>In conclusion, SAPS II and SOFA scores not only predict ICU and hospital lengths of stay but also independently forecast overall survival in patients undergoing CRS and HIPEC for PSM.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fsurg.2025.1664710","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:38:33Z","timestamp":1761025113000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Intensive care scores predict outcomes in patients receiving cytoreductive surgery and hyperthermic intraperitoneal chemotherapy"],"prefix":"10.3389","volume":"12","author":[{"given":"Julia","family":"Wimmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miklos","family":"Acs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyula","family":"Bohus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Hauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Bogovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Kupke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Przemyslaw","family":"Slowik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J.","family":"Schlitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Hornung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens M.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1245\/s10434-025-17518-z","article-title":"National guidelines for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal malignancies: a worldwide systematic review and recommendations of strength analysis","volume":"32","author":"Tonello","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4251\/wjgo.v8.i1.67","article-title":"Multimodality treatment strategies have changed prognosis of peritoneal metastases","volume":"8","author":"Lungoci","year":"2016","journal-title":"World J Gastrointest Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"B4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-0-387-48993-3_15","article-title":"Peritonectomy procedures","volume-title":"Peritoneal Carcinomatosis: A Multidisciplinary Approach. Cancer Treatment and Research","author":"Sugarbaker","year":"2007"},{"key":"B5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/jso.21388","article-title":"Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies","volume":"100","author":"Deraco","year":"2009","journal-title":"J Surg Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1245\/s10434-018-6992-6","article-title":"Morbidity and mortality following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: data from the DGAV StuDoQ registry with 2,149 consecutive patients","volume":"26","author":"Piso","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/jso.24248","article-title":"What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1,125 procedures","volume":"113","author":"Passot","year":"2016","journal-title":"J Surg Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/cancers14235824","article-title":"Complications and mortality rate of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: italian peritoneal surface malignancies oncoteam results analysis","volume":"14","author":"Carboni","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.5492\/wjccm.v11.i6.375","article-title":"Postoperative complications and critical care management after cytoreduction surgery and hyperthermic intraperitoneal chemotherapy: a systematic review of the literature","volume":"11","author":"Wajekar","year":"2022","journal-title":"World J Crit Care Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction\/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","article-title":"Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a multicenter, prospective study. Working group on sepsis-related problems of the European society of intensive care medicine","volume":"26","author":"Vincent","year":"1998","journal-title":"Crit Care Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.270.24.2957","article-title":"A new simplified acute physiology score (SAPS II) based on a European\/north American multicenter study","volume":"270","author":"Le Gall","year":"1993","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1159\/000503095","article-title":"Performance status assessment by using ECOG (eastern cooperative oncology group) score for cancer patients by oncology healthcare professionals","volume":"12","author":"Azam","year":"2019","journal-title":"Case Rep Oncol"},{"key":"B14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume-title":"Peritoneal Carcinomatosis: Principles of Management. Cancer Treatment and Research","author":"Jacquet","year":"1996"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.21873\/invivo.12840","article-title":"Selection criteria for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with special emphasis on laparoscopy as an efficient tool","volume":"36","author":"Acs","year":"2022","journal-title":"In Vivo"},{"key":"B16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/0019-5049.79879","article-title":"American Society of anaesthesiologists physical status classification","volume":"55","author":"Daabiss","year":"2011","journal-title":"Indian J Anaesth"},{"key":"B17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/s1055-3207(03)00037-1","article-title":"Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma","volume":"12","author":"Glehen","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1245\/s10434-014-3987-9","article-title":"Peritoneal surface disease with synchronous hepatic involvement treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"22","author":"Randle","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"B19","first-page":"518","article-title":"Proposed classification of complications of surgery with examples of utility in cholecystectomy","volume":"111","author":"Clavien","year":"1992","journal-title":"Surgery"},{"key":"B20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s13054-019-2663-7","article-title":"The SOFA score: development, utility and challenges of accurate assessment in clinical trials","volume":"23","author":"Lambden","year":"2019","journal-title":"Crit Care"},{"key":"B22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/1460458209353558","article-title":"Automating and simplifying the SOFA score in critically ill patients with cancer","volume":"16","author":"Nates","year":"2010","journal-title":"Health Inform J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/00003246-200202000-00012","article-title":"Discriminative power on mortality of a modified sequential organ failure assessment score for complete automatic computation in an operative intensive care unit","volume":"30","author":"Junger","year":"2002","journal-title":"Crit Care Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"R72","DOI":"10.1186\/cc2331","article-title":"Outcome after acute respiratory failure is more dependent on dysfunction in other vital organs than on the severity of the respiratory failure","volume":"7","author":"Flaatten","year":"2003","journal-title":"Crit Care"},{"key":"B25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1053\/jcan.2001.24983","article-title":"Application of modified sequential organ failure assessment score in children in cardiac surgery","volume":"15","author":"Shime","year":"2001","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"B26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1399-6576.2008.01825.x","article-title":"Accuracy of sequential organ failure assessment (SOFA) scoring in clinical practice","volume":"53","author":"Tallgren","year":"2009","journal-title":"Acta Anaesthesiol Scand"},{"key":"B27","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ejso.2016.03.004","article-title":"No impact on long-term survival of prolonged ICU stay and re-admission for patients undergoing cytoreductive surgery with HIPEC","volume":"42","author":"Wallet","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00423-012-0966-0","article-title":"Outcome in patients with long-term treatment in a surgical intensive care unit","volume":"397","author":"Weiler","year":"2012","journal-title":"Langenbecks Arch Surg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s13193-016-0504-6","article-title":"Complications of cytoreductive surgery and HIPEC in the treatment of peritoneal metastases","volume":"7","author":"Mehta","year":"2016","journal-title":"Indian J Surg Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00423-014-1253-z","article-title":"Morbidity, mortality and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"400","author":"Desantis","year":"2015","journal-title":"Langenbecks Arch Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/SLA.0b013e31825704e3","article-title":"Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"256","author":"Baratti","year":"2012","journal-title":"Ann Surg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/pubmed\/fdl048","article-title":"Decision-making and technical factors account for the learning curve in complex surgery","volume":"28","author":"Moran","year":"2006","journal-title":"J Public Health (Oxf)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/PPO.0b013e3181a58d56","article-title":"Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve","volume":"15","author":"Mohamed","year":"2009","journal-title":"Cancer J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1245\/s10434-007-9406-8","article-title":"Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy: a journey to becoming a nationally funded peritonectomy center","volume":"18","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ejso.2020.07.041","article-title":"Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS\u00ae) society recommendations \u2013 part I: preoperative and intraoperative management","volume":"46","author":"Hubner","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1245\/s10434-019-07900-z","article-title":"Implementation of an enhanced recovery after surgery (ERAS) program is associated with improved outcomes in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"27","author":"Webb","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1080\/02656736.2017.1291999","article-title":"Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma","volume":"33","author":"Lemoine","year":"2017","journal-title":"Int J Hyperthermia"},{"key":"B38","volume-title":"S3-Leitlinie Kolorektales Karzinom: Langversion 2.1 \u2013 Januar 2019","year":"2019"},{"key":"B39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00104-020-01112-y","article-title":"[S3 guidelines on gastric cancer\u2014diagnosis and treatment of adenocarcinoma of the stomach and esophagogastric junction: version 2.0\u2013August 2019. AWMF register number: 032\/009OL]","volume":"91","author":"M\u00f6nig","year":"2020","journal-title":"Chirurg"},{"key":"B40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Quenet","year":"2021","journal-title":"Lancet Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1245\/s10434-010-1415-3","article-title":"Hepatobiliary procedures in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"18","author":"Glockzin","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3109\/02656736.2016.1149233","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer","volume":"32","author":"Polom","year":"2016","journal-title":"Int J Hyperthermia"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2025.1664710\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:38:35Z","timestamp":1761025115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2025.1664710\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":42,"alternative-id":["10.3389\/fsurg.2025.1664710"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2025.1664710","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"article-number":"1664710"}}